Abstract

4571Background: Combination of a VEGF receptor inhibitor with immunotherapy could be a strategy to enhance antitumor efficacy in advanced RCC. A phase I trial by our group showed that pazopanib plu...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Phase I study of pazopanib in combination with interferon alfa in patients with advanced renal cell carcinoma (RCC) and other primary tumors: A Spanish Oncology Genitourinary Group (SOGUG) study.
Xavier Garcia Del Muro ... Juan Francisco Rodriguez-Moreno
Journal of Clinical Oncology | VOL. 32
Xavier Garcia Del Muro, et. al.Xavier Garcia Del Muro ... Juan Francisco Rodriguez-Moreno
01 Feb 2014
Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study.
... Ricardo Sánchez-Escribano
BMC Cancer | VOL. 16
, et. al. ... Ricardo Sánchez-Escribano
22 Feb 2016
Updated recommendations from the Spanish Oncology Genitourinary Group on the treatment of advanced renal cell carcinoma
Emiliano Calvo ... Luis Paz-Ares
Cancer and Metastasis Review | VOL. 29
Emiliano Calvo, et. al.Emiliano Calvo ... Luis Paz-Ares
17 Jul 2010
Treatment Algorithms in Metastatic Renal Cell Carcinoma, Including the Potential Role of the Novel Oral Mammalian Target of Rapamycin Inhibitor Everolimus
Jean-Jacques Patard
European Urology Open Science | VOL. 8
Jean-Jacques PatardJean-Jacques Patard
09 Sep 2009
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Leptomeningeal Metastasis in the Era of CNS-Penetrant Tyrosine Kinase Inhibitor Therapy.
Mark Y Jeng ... Helena A Yu
Journal of Clinical Oncology | VOL. 42
Mark Y Jeng, et. al.Mark Y Jeng ... Helena A Yu
10 Aug 2024
Management of Locally Advanced Rectal Cancer: ASCO Guideline.
Aaron J Scott ... Sepideh Gholami
Journal of Clinical Oncology | VOL. -
Aaron J Scott, et. al.Aaron J Scott ... Sepideh Gholami
08 Aug 2024
Comments and Controversies in Oncology: The Tribulations of Trials Developing ONC201.
Jordan R Hansford ... Eric Bouffet
Journal of Clinical Oncology | VOL. -
Jordan R Hansford, et. al.Jordan R Hansford ... Eric Bouffet
07 Aug 2024
Corticosteroids for Immune-Related Adverse Events and Checkpoint Inhibitor Efficacy: Analysis of Six Clinical Trials.
Rik J Verheijden ... Karijn P M Suijkerbuijk
Journal of Clinical Oncology | VOL. -
Rik J Verheijden, et. al.Rik J Verheijden ... Karijn P M Suijkerbuijk
07 Aug 2024
View more papers